Patents by Inventor Joseph J. Eiden

Joseph J. Eiden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
    Publication number: 20030216340
    Abstract: Methods are provided for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. A polynucleotide comprising an immunostimulatory sequence is administered to a individual who has been exposed to or infected by HBV and/or HCV. The polynucleotide is not administered with a HCV or HBV antigen. Administration of the polynucleotide results in amelioration of symptoms of HBV and/or HCV infection.
    Type: Application
    Filed: February 3, 2003
    Publication date: November 20, 2003
    Inventors: Gary Van Nest, Joseph J. Eiden
  • Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
    Publication number: 20020107212
    Abstract: The invention provides methods for the treatment of papillomavirus infections. A polynucleotide comprising an immunstimulatory sequence is administered to an individual who has been exposed to or infected by papillomavirus. The polynucleotide is not administered with papillomavirus antigen. Administration of the polynucleotide results in amelioration of symptoms of papillomavirus infection.
    Type: Application
    Filed: March 9, 2001
    Publication date: August 8, 2002
    Inventors: Gary Van Nest, Joseph J. Eiden
  • Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
    Publication number: 20020098199
    Abstract: Methods are provided for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. A polynucleotide comprising an immunostimulatory sequence is administered to a individual who has been exposed to or infected by HBV and/or HCV. The polynucleotide is not administered with a HCV or HBV antigen. Administration of the polynucleotide results in amelioration of symptoms of HBV and/or HCV infection.
    Type: Application
    Filed: March 9, 2001
    Publication date: July 25, 2002
    Inventors: Gary Van Nest, Joseph J. Eiden